Imagine a patient walks in with fever, headache, vomiting, diarrhea, and severe fatigue. Is it Ebola? Probably not — even in the middle of an Ebola outbreak. And understanding why is one of the most important lessons in outbreak medicine.
The Outbreak Happening Right Now
In May 2026, the Democratic Republic of Congo (DRC) declared an Ebola outbreak caused by the Bundibugyo strain, in the Ituri province. The World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) — the highest level of global health alert.
But here is something that rarely makes the headlines: during any Ebola outbreak, the vast majority of suspected cases are not Ebola. Most turn out to be something else entirely. Something common. Something treatable. Something that has been circulating in the region long before the virus arrived.
The Problem: Ebola Looks Like Everything Else — at First
The early symptoms of Ebola are what doctors call nonspecific. This means they do not point to one specific disease. They point to many.
Fever. Headache. Fatigue. Muscle pain. Sore throat. Vomiting. Diarrhea.
Sound familiar? That is because those are also the symptoms of malaria — the most common infectious disease in the DRC, affecting tens of millions of people every year. They are also the symptoms of cholera, typhoid fever, and respiratory infections, all of which circulate constantly in the region.
The WHO itself has acknowledged this challenge explicitly, noting that early symptoms are nonspecific in a way that complicates clinical diagnosis and can delay detection. Differentiating Bundibugyo disease from other endemic febrile illnesses — especially malaria — is extremely difficult without laboratory confirmation.
Health workers and community members on the ground say the same thing: they are used to seeing outbreaks of cholera, typhoid, and malaria all the time. It is genuinely hard to know what is Ebola and what is not.
Comparing the Diseases Side by Side
This table shows how Ebola compares to other common diseases in the DRC — and why the clinical picture alone is never enough to make the diagnosis.
| Disease | Symptoms that overlap with Ebola | How common in the DRC |
|---|---|---|
| Malaria | Fever, headache, weakness, vomiting | Extremely high — tens of millions of cases/year |
| Cholera / infectious diarrhea | Diarrhea, vomiting, dehydration | High — frequent outbreaks |
| Typhoid fever | Prolonged fever, abdominal pain | Common |
| Respiratory infections | Fever, cough, weakness | Very common |
| Ebola (Bundibugyo) | All of the above + possible bleeding (later) | Rare — but with high fatality rate |
Notice something important: bleeding — the symptom most people associate with Ebola — typically appears late in the disease, not at the beginning. In the early days, there is often nothing that visually separates an Ebola patient from someone with a bad case of malaria.
What This Means in Practice
During the current outbreak, hundreds of suspected cases are being investigated — and most of them will test negative for Ebola. That is not a failure of the surveillance system. That is the system working correctly: casting a wide net, testing everyone who meets the criteria, and ruling out the virus with laboratory confirmation.
The clinical protocol is not "everyone with fever = Ebola." The correct approach is systematic and layered:
First: assess whether the person has had contact with a confirmed case or attended a funeral in the affected area. Exposure history is the most important early filter.
Second: run a rapid malaria test. It is cheap, fast, and widely available — and malaria needs to be ruled out immediately because it has specific treatment that cannot be delayed.
Third: investigate other local diagnoses based on the clinical picture.
Only then: if the exposure history is significant and other diagnoses do not explain the symptoms, proceed to the specific Ebola RT-PCR test.
There is one more complexity worth knowing: the CDC explicitly warns that co-infections are possible. A patient can have malaria and Ebola at the same time. This makes clinical management significantly more difficult — and reinforces why laboratory confirmation is non-negotiable.
A Case from Brazil That Illustrates the Same Principle
When I was practicing medicine in Porto Velho — the capital of Rondônia, a state in the Brazilian Amazon — I saw a patient whose presentation strongly suggested acute toxoplasmosis. The symptoms fit. The clinical reasoning pointed in that direction.
I ordered the toxoplasmosis test. But then I remembered something fundamental: Rondônia is a region with very high malaria transmission. And malaria — especially in some of its presentations — can mimic toxoplasmosis closely, including neurological features and fever patterns.
So alongside the toxoplasmosis test, I ordered a malaria test as well. The result came back: malaria positive. The diagnosis the symptoms pointed to most obviously was not the correct one. If I had stopped at the first hypothesis, the patient would have received the wrong treatment — and the real disease would have gone untreated.
This is not a rare or unusual situation. It is, in fact, one of the core principles of clinical medicine in regions with endemic infectious diseases: when you are in a place where certain diseases are common, you have to investigate those diseases too — even when the presentation suggests something else.
The lesson translates directly to outbreak settings. During an Ebola outbreak in a region where malaria is endemic, "think Ebola" cannot mean "stop thinking about everything else." The differential diagnosis must remain broad. The tests must be appropriate to the local epidemiology. And the laboratory — not the clinical presentation alone — must close the diagnosis.
Why This Matters for You
If you are a healthcare professional working in or preparing for deployment to an outbreak zone, this principle shapes everything: your triage criteria, your personal protective equipment decisions, your resource allocation, and your communication with patients and families.
If you are a traveler or a member of the public following the news: understanding this dynamic helps you interpret outbreak reports more accurately. When you read that "hundreds of suspected cases are under investigation," that does not mean hundreds of people have Ebola. It means hundreds of people have symptoms that require investigation — and most of them will be something else.
Accurate information during an outbreak is protective. Panic is not.
The Bottom Line
Ebola is a severe, life-threatening disease. The current Bundibugyo outbreak in the DRC deserves serious attention and a serious global response.
But during an outbreak, the most important diagnostic skill is not pattern recognition for Ebola. It is the discipline to keep the differential diagnosis open — to test for the most common local diseases, to rule them out systematically, and to let the laboratory guide the final answer.
Not every fever is Ebola. Not every death during an outbreak is caused by the virus. And the ability to distinguish what is Ebola from what is not — calmly, methodically, with the right tests — is what ultimately determines whether an outbreak is controlled or allowed to spread.
Stay ahead with physician-led IPC intelligence and online certification courses.
View All Courses →